{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:13:03Z","timestamp":1791072783641,"version":"4.1.0"},"reference-count":101,"publisher":"Bentham Science Publishers Ltd.","issue":"9","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Cancer remains a major concern, accounting for one in six deaths globally. Developing\neffective treatments is challenging due to the complex mechanisms involving environmental, genetic,\nand epigenetic factors. Animal toxins have been utilized as pharmacological agents for treating several\ndiseases. Among these compounds, melittin, derived from bee venom, exhibits significant therapeutic\npotential against cancer. This efficacy is attributed to its multifaceted nature, enabling it to\nfunction as a multi-target modulator of oncogenic signaling pathways and exert a broad spectrum of\nanticancer effects. In vitro studies have demonstrated that melittin treatment reduces cell viability,\nadhesion, clonogenic survival, migration, and invasion in various cancer cell types. Additionally, in\nvitro experiments have demonstrated that melittin induces apoptosis through multiple mechanisms,\nsuch as upregulating TNF-\u03b1 and BAX, triggering ferroptosis, activating the mitochondrial pathway,\ninitiating endoplasmic reticulum stress, and inhibiting METTL3. Furthermore, in vivo assays indicate\nthat melittin reduces angiogenesis and tumor growth, enhances the effects of chemotherapy, and\nprolongs survival. The effects of melittin on the tumor microenvironment, modulation of the epigenetic\nprocess, and inhibition of the epithelial-mesenchymal transition have also been demonstrated.\nOverall, melittin shows potential as a therapeutic agent for breast, lung, gastric, cervical, colorectal,\nand bladder cancers by targeting multiple pathways involved in cancer progression. Moreover, other\nbee venom components, such as apamin and bee venom phospholipase A2, also exhibit potential\nanticancer effects. In this review, a comprehensive overview of the various actions of melittin and\nother components of bee venom on different types of cancer is provided. The research discusses their\nmechanisms of action and potential strategies to enhance efficacy and minimize toxicity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0113894501424902260115203324","type":"journal-article","created":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:55:10Z","timestamp":1774439710000},"page":"585-599","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Bee Venom and Cancer: A Mini-review Focusing on Melittin Antitumoral Effects"],"prefix":"10.2174","volume":"27","author":[{"given":"Ana Maria Boaventura","family":"de Oliveira","sequence":"first","affiliation":[{"name":"Laboratory of Pain and Signaling, Butantan Institute, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane Roquete","family":"Amparo","sequence":"additional","affiliation":[{"name":"Postgraduate Program in Pharmaceutical Sciences, University Federal of Ouro Preto, Ouro Preto, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morena Brazil Martins","family":"Sant\u2019Anna","sequence":"additional","affiliation":[{"name":"Laboratory of Pain and Signaling, Butantan Institute, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisele","family":"Picolo","sequence":"additional","affiliation":[{"name":"Laboratory of Pain and Signaling, Butantan Institute, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamires Cunha","family":"Almeida","sequence":"additional","affiliation":[{"name":"Laboratory of Pain and Signaling, Butantan Institute, Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"Bray F.","year":"2024","unstructured":"Bray F.; Laversanne M.; Sung H.; Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin  2024,74(3),229-63","journal-title":"CA Cancer J Clin"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/9781119645214.ch1","author":"Stein G.S.","year":"2019","unstructured":"Stein G.S.; Luebbers K.P.; Cancer and the cancer experience. In: Cancer  2019,1-11","journal-title":"In: Cancer"},{"key":"ref=3","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-68134-0","author":"Melchior L.A.K.","year":"2021","unstructured":"Melchior L.A.K.; Meneguetti D.U. de O.; Camargo L.M.A.; de Oliveira J.; Current topics in tropical medicine in South America: Veterinary medicine. In: Current Topics in Tropical Medicine in South America: Veterinary Medicine  2021","journal-title":"In: Current Topics in Tropical Medicine in South America: Veterinary Medicine"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.3390\/molecules24162997","volume":"24","author":"Wehbe R.","year":"2019","unstructured":"Wehbe R.; Frangieh J.; Rima M.; El Obeid D.; Sabatier J.M.; Fajloun Z.; Bee Venom: Overview of main compounds and bioactivities for therapeutic interests. Molecules  2019,24(16),2997","journal-title":"Molecules"},{"key":"ref=5","doi-asserted-by":"publisher","DOI":"10.36255\/exon-publications.breast-cancer.2022.ch3","author":"Orrantia-Borunda E.","year":"2022","unstructured":"Orrantia-Borunda E.; Anchondo-Nu\u00f1ez P.; Acu\u00f1a-Aguilar L.E.; G\u00f3mez-Valles F.O.; Ram\u00edrez-Valdespino C.A.; Breast Cancer. Brisbane (AU): Exon Publications  2022","journal-title":"Brisbane (AU): Exon Publications"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.canlet.2020.10.016","volume":"497","author":"Bai X.","year":"2021","unstructured":"Bai X.; Ni J.; Beretov J.; Graham P.; Li Y.; Triple-negative breast cancer therapeutic resistance: Where is the achilles\u2019 heel? Cancer Lett  2021,497,100-111","journal-title":"Cancer Lett"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41698-020-00129-0","volume":"4","author":"Duffy C.","year":"2020","unstructured":"Duffy C.; Sorolla A.; Wang E.; Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer. NPJ Precis Oncol  2020,4(1),24","journal-title":"NPJ Precis Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.7150\/jca.57334","volume":"12","author":"Ghosh C.","year":"2021","unstructured":"Ghosh C.; Luong G.; Sun Y.; A snapshot of the PD-1\/PD-L1 pathway. J Cancer  2021,12(9),2735-46","journal-title":"J Cancer"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/14737140.2022.2023011","volume":"22","author":"Latif F.","year":"2022","unstructured":"Latif F.; Bint Abdul Jabbar H.; Malik H.; Atezolizumab and pembrolizumab in triple-negative breast cancer: A meta-analysis. Expert Rev Anticancer Ther  2022,22(2),229-35","journal-title":"Expert Rev Anticancer Ther"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12032-021-01526-6","volume":"38","author":"Mir Hassani Z.","year":"2021","unstructured":"Mir Hassani Z.; Nabiuni M.; Parivar K.; Abdirad S.; Karimzadeh L.; Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1\u03b1 signaling in breast cancer cells. Med Oncol  2021,38(7),77","journal-title":"Med Oncol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.bbamcr.2015.05.036","volume":"1863","author":"Semenza G.L.","year":"2016","unstructured":"Semenza G.L.; The hypoxic tumor microenvironment: A driving force for breast cancer progression. Biochim Biophys Acta Mol Cell Res  2016,1863(3),382-91","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/01.ATV.0000258979.92828.bc","volume":"27","author":"Bonello S.","year":"2007","unstructured":"Bonello S.; Z\u00e4hringer C.; BelAiba R.S.; Reactive oxygen species activate the HIF-1\u03b1 promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol  2007,27(4),755-61","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"6834","DOI":"10.3390\/ijms24076834","volume":"24","author":"Clusan L.","year":"2023","unstructured":"Clusan L.; Ferri\u00e8re F.; Flouriot G.; Pakdel F.; A basic review on estrogen receptor signaling pathways in breast cancer. Int J Mol Sci  2023,24(7),6834","journal-title":"Int J Mol Sci"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1158\/1078-0432.CCR-13-0838","volume":"19","author":"Zhang X.H.F.","year":"2013","unstructured":"Zhang X.H.F.; Giuliano M.; Trivedi M.V.; Schiff R.; Osborne C.K.; Metastasis dormancy in estrogen receptor-positive breast cancer. Clin Cancer Res  2013,19(23),6389-97","journal-title":"Clin Cancer Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.fct.2014.03.022","volume":"68","author":"Jeong Y.J.","year":"2014","unstructured":"Jeong Y.J.; Choi Y.; Shin J.M.; Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K\/Akt\/mTOR signaling pathway in breast cancer cells. Food Chem Toxicol  2014,68,218-225","journal-title":"Food Chem Toxicol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1083\/jcb.201406102","volume":"208","author":"Johnson H.E.","year":"2015","unstructured":"Johnson H.E.; King S.J.; Asokan S.B.; Rotty J.D.; Bear J.E.; Haugh J.M.; F-actin bundles direct the initiation and orientation of lamellipodia through adhesion-based signaling. J Cell Biol  2015,208(4),443-55","journal-title":"J Cell Biol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.3390\/s18103249","volume":"18","author":"Huang H.","year":"2018","unstructured":"Huang H.; Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances. Sensors  2018,18(10),3249","journal-title":"Sensors"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"Dongre A.","year":"2019","unstructured":"Dongre A.; Weinberg R.A.; New insights into the mechanisms of epithelial\u2013mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol  2019,20(2),69-84","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3892\/ol.2016.5516","volume":"13","author":"Wang J.","year":"2017","unstructured":"Wang J.; Li F.; Tan J.; Melittin inhibits the invasion of MCF-7 cells by downregulating CD147 and MMP-9 expression. Oncol Lett  2017,13(2),599-604","journal-title":"Oncol Lett"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ccm.2019.10.001","volume":"41","author":"Bade B.C.","year":"2020","unstructured":"Bade B.C.; Dela Cruz C.S.; Lung cancer 2020. Clin Chest Med  2020,41(1),1-24","journal-title":"Clin Chest Med"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"54951","DOI":"10.18632\/oncotarget.18627","volume":"8","author":"Lee C.","year":"2017","unstructured":"Lee C.; Bae S.J.S.; Joo H.; Bae H.; Melittin suppresses tumor progression by regulating tumor-associated macrophages in a Lewis lung carcinoma mouse model. Oncotarget  2017,8(33),54951-65","journal-title":"Oncotarget"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Xiao Y.","year":"2021","unstructured":"Xiao Y.; Yu D.; Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther  2021,221,107753","journal-title":"Pharmacol Ther"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1189\/jlb.1105656","volume":"80","author":"Lamagna C.","year":"2006","unstructured":"Lamagna C.; Aurrand-Lions M.; Imhof B.A.; Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol  2006,80(4),705-13","journal-title":"J Leukoc Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.31557\/APJCP.2018.19.12.3427","volume":"19","author":"Tipgomut C.","year":"2018","unstructured":"Tipgomut C.; Wongprommoon A.; Takeo E.; Ittiudomrak T.; Puthong S.; Chanchao C.; Melittin induced g1 cell cycle arrest and apoptosis in chago-K1 human bronchogenic carcinoma cells and inhibited the differentiation of THP-1 cells into tumour- associated macrophages. Asian Pac J Cancer Prev  2018,19(12),3427-3434","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e9017-7","DOI":"10.1590\/1414-431X20209017","volume":"54","author":"Yu R.","year":"2020","unstructured":"Yu R.; Wang M.; Wang M.; Han L.; Melittin suppresses growth and induces apoptosis of non-small-cell lung cancer cells via down-regulation of TGF-\u03b2-mediated ERK signal pathway. Braz J Med Biol Res  2020,54(2),e9017-7","journal-title":"Braz J Med Biol Res"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3892\/ijmm.2017.2851","volume":"39","author":"Shi S.","year":"2017","unstructured":"Shi S.; Zhao J.; Wang J.; Mi D.; Ma Z.; HPIP silencing inhibits TGF-\u03b21-induced EMT in lung cancer cells. Int J Mol Med  2017,39(2),479-83","journal-title":"Int J Mol Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"791272","DOI":"10.3389\/fphar.2022.791272","volume":"13","author":"Baba A.B.","year":"2022","unstructured":"Baba A.B.; Rah B.; Bhat G.R.; Transforming growth factor-beta (TGF-\u03b2) signaling in cancer-A betrayal within. Front Pharmacol  2022,13,791272","journal-title":"Front Pharmacol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.3892\/mmr.2017.6970","volume":"16","author":"Zhang S.F.","year":"2017","unstructured":"Zhang S.F.; Chen Z.; Melittin exerts an antitumor effect on non-small cell lung cancer cells. Mol Med Rep  2017,16(3),3581-6","journal-title":"Mol Med Rep"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.2147\/OTT.S169806","volume":"11","author":"Gao D.","year":"2018","unstructured":"Gao D.; Zhang J.; Bai L.; Li F.; Dong Y.; Li Q.; Melittin induces NSCLC apoptosis via inhibition of miR-183. OncoTargets Ther  2018,11,4511-23","journal-title":"OncoTargets Ther"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.biopha.2018.12.115","volume":"111","author":"Wang H.","year":"2019","unstructured":"Wang H.; Ma Z.; Liu X.; MiR-183-5p is required for non-small cell lung cancer progression by repressing PTEN. Biomed Pharmacother  2019,111,1103-1111","journal-title":"Biomed Pharmacother"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"e9700-0","DOI":"10.1590\/1414-431X20209700","volume":"54","author":"Huang Y.","year":"2021","unstructured":"Huang Y.; Zhang M.; Li Y.; Luo J.; Wang Y.; Geng W.; miR-183 promotes radioresistance of lung adenocarcinoma H1299 cells via epithelial-mesenchymal transition. Braz J Med Biol Res  2021,54(5),e9700-0","journal-title":"Braz J Med Biol Res"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1080\/10715762.2022.2131551","volume":"56","author":"Li X.","year":"2022","unstructured":"Li X.; Zhu S.; Li Z.; Melittin induces ferroptosis and ER stress-CHOP-mediated apoptosis in A549 cells. Free Radic Res  2022,56(5-6),398-410","journal-title":"Free Radic Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"McGlynn K.A.","year":"2021","unstructured":"McGlynn K.A.; Petrick J.L.; El-Serag H.B.; Epidemiology of hepatocellular carcinoma. Hepatology  2021,73(S1),4-13","journal-title":"Hepatology"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","volume":"77","author":"Vithayathil M.","year":"2022","unstructured":"Vithayathil M.; Khan S.A.; Current epidemiology of cholangiocarcinoma in Western countries. J Hepatol  2022,77(6),1690-8","journal-title":"J Hepatol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","volume":"67","author":"Marengo A.","year":"2016","unstructured":"Marengo A.; Rosso C.; Bugianesi E.; Liver Cancer: Connections with obesity, fatty liver, and cirrhosis. Annu Rev Med  2016,67(1),103-117","journal-title":"Annu Rev Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"115683","DOI":"10.1016\/j.envres.2023.115683","volume":"227","author":"Alqurashi Y.E.","year":"2023","unstructured":"Alqurashi Y.E.; Al-Hetty H.R.A.K.; Ramaiah P.; Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint. Environ Res  2023,227,115683","journal-title":"Environ Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/9602935","volume":"2019","author":"Chen Q.","year":"2019","unstructured":"Chen Q.; Lin W.; Yin Z.; Zou Y.; Liang S.; Ruan S.; Melittin inhibits hypoxia-induced vasculogenic mimicry formation and epithelialmesenchymal transition through suppression of HIF-1 math id=\u201cM1\u201d mrow mtext mathvariant=\u201cbold\u201d\u03b1\/mtext \/mrow \/math \/Akt pathway in liver cancer. Evid Based Complement Alternat Med  2019,2019,1-10","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3390\/toxins9040138","volume":"9","author":"Park J.H.","year":"2017","unstructured":"Park J.H.; Park B.; Park K.K.; Suppression of hepatic epithelial-to-mesenchymal transition by melittin via blocking of TGF\u03b2\/Smad and MAPK-JNK signaling pathways. Toxins  2017,9(4),138","journal-title":"Toxins"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1091\/mbc.e04-08-0658","volume":"16","author":"Valcourt U.","year":"2005","unstructured":"Valcourt U.; Kowanetz M.; Niimi H.; Heldin C.H.; Moustakas A.; TGF-\u03b2 and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell  2005,16(4),1987-2002","journal-title":"Mol Biol Cell"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"95520","DOI":"10.1371\/journal.pone.0095520","volume":"9","author":"Zhang H.","year":"2014","unstructured":"Zhang H.; Zhao B.; Huang C.; Meng X.M.; Bian E.B.; Li J.; Melittin restores PTEN expression by down-regulating HDAC2 in human hepatocelluar carcinoma HepG2 cells. PLoS One  2014,9(5),95520","journal-title":"PLoS One"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"106996","DOI":"10.1016\/j.toxicon.2022.106996","volume":"222","author":"Lv C.","year":"2023","unstructured":"Lv C.; Chen J.; Huang F.; Fang F.; Li B.; Melittin inhibits the proliferation migration and invasion of HCC cells by regulating ADAMTS9-AS2 demethylation. Toxicon  2023,222,106996","journal-title":"Toxicon"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1136\/gutjnl-2019-320234","volume":"69","author":"Arnold M.","year":"2020","unstructured":"Arnold M.; Park J.Y.; Camargo M.C.; Lunet N.; Forman D.; Soerjomataram I.; Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut  2020,69(5),823-829","journal-title":"Gut"},{"key":"ref=43","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.27.920744","author":"Yoo S.","year":"2020","unstructured":"Yoo S.; Chen Q.; Wang L.; Wang W.; Chakravarthy A.; Busuttil R.; Molecular and cellular heterogeneity of gastric cancer explained by methylation-driven key regulators. bioRxiv  2020","journal-title":"bioRxiv"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.3748\/wjg.v22.i11.3186","volume":"22","author":"Kong G.M.","year":"2016","unstructured":"Kong G.M.; Tao W.H.; Diao Y.L.; Melittin induces human gastric cancer cell apoptosis via activation of mitochondrial pathway. World J Gastroenterol  2016,22(11),3186-95","journal-title":"World J Gastroenterol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/bbb\/zbab153","volume":"85","author":"Huang J.Y.","year":"2021","unstructured":"Huang J.Y.; Peng S.F.; Chueh F.S.; Melittin suppresses epithelial\u2013mesenchymal transition and metastasis in human gastric cancer AGS cells via regulating Wnt\/BMP associated pathway. Biosci Biotechnol Biochem  2021,85(11),2250-62","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.jcma.2015.06.008","volume":"78","author":"Mahmoodzadeh A.","year":"2015","unstructured":"Mahmoodzadeh A.; Zarrinnahad H.; Bagheri K.P.; Moradia A.; Shahbazzadeh D.; First report on the isolation of melittin from Iranian honey bee venom and evaluation of its toxicity on gastric cancer AGS cells. J Chin Med Assoc  2015,78(10),574-83","journal-title":"J Chin Med Assoc"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"0224028","DOI":"10.1371\/journal.pone.0224028","volume":"14","author":"Soliman C.","year":"2019","unstructured":"Soliman C.; Eastwood S.; Truong V.K.; Ramsland P.A.; Elbourne A.; The membrane effects of melittin on gastric and colorectal cancer. PLoS One  2019,14(10),0224028","journal-title":"PLoS One"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1136\/gutjnl-2018-317592","volume":"68","author":"Vuik F.E.R.","year":"2019","unstructured":"Vuik F.E.R.; Nieuwenburg S.A.V.; Bardou M.; Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut  2019,68(10),1820-6","journal-title":"Gut"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1136\/gutjnl-2019-319511","volume":"68","author":"Siegel R.L.","year":"2019","unstructured":"Siegel R.L.; Torre L.A.; Soerjomataram I.; Global patterns and trends in colorectal cancer incidence in young adults. Gut  2019,68(12),2179-85","journal-title":"Gut"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"Dekker E.","year":"2019","unstructured":"Dekker E.; Tanis P.J.; Vleugels J.L.A.; Kasi P.M.; Wallace M.B.; Colorectal cancer. Lancet  2019,394(10207),1467-1480","journal-title":"Lancet"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"e20210067","DOI":"10.1590\/1678-9199-JVATITD-2021-0067","volume":"28","author":"Rocha M.M.","year":"2022","unstructured":"Rocha M.M.; Dariva I.; Zornoff G.C.; De Laurentis G.S.; Mendes G.C.; Santana M.G.; A new therapeutic approach for bone metastasis in colorectal cancer: Intratumoral melittin. J Venom Anim Toxins Incl Trop Dis  2022,28,e20210067","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1093\/jpp\/rgad008","volume":"75","author":"Luo Y.","year":"2023","unstructured":"Luo Y.; Xu C.; Luo B.; Liang G.; Zhang Q.; Melittin treatment prevents colorectal cancer from progressing in mice through ER stress-mediated apoptosis. J Pharm Pharmacol  2023,75(5),645-654","journal-title":"J Pharm Pharmacol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/toxins15070459","volume":"15","author":"R\u0103ileanu M.","year":"2023","unstructured":"R\u0103ileanu M.; Bacalum M.; Cancer Wars: Revenge of the AMPs (Antimicrobial Peptides), a New Strategy against Colorectal Cancer. Toxins  2023,15(7),459","journal-title":"Toxins"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12929-024-00994-y","volume":"31","author":"Abuwatfa W.H.","year":"2024","unstructured":"Abuwatfa W.H.; Pitt W.G.; Husseini G.A.; Scaffold-based 3D cell culture models in cancer research. J Biomed Sci  2024,31(1),7","journal-title":"J Biomed Sci"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"0261503","DOI":"10.1371\/journal.pone.0261503","volume":"17","author":"Br\u00fcggmann D.","year":"2022","unstructured":"Br\u00fcggmann D.; Quinkert-Schmolke K.; Jaque J.M.; Global cervical cancer research: A scientometric density equalizing mapping and socioeconomic analysis. PLoS One  2022,17(1),0261503","journal-title":"PLoS One"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.soncn.2019.02.003","volume":"35","author":"Johnson C.A.","year":"2019","unstructured":"Johnson C.A.; James D.; Marzan A.; Armaos M.; Cervical Cancer: An overview of pathophysiology and management. Semin Oncol Nurs  2019,35(2),166-74","journal-title":"Semin Oncol Nurs"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s10989-017-9641-1","volume":"24","author":"Zarrinnahad H.","year":"2018","unstructured":"Zarrinnahad H.; Mahmoodzadeh A.; Hamidi M.P.; Apoptotic effect of melittin purified from iranian honey bee venom on human cervical cancer hela cell line. Int J Pept Res Ther  2018,24(4),563-70","journal-title":"Int J Pept Res Ther"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3390\/molecules27051653","volume":"27","author":"Yaacoub C.","year":"2022","unstructured":"Yaacoub C.; Wehbe R.; Salma Y.; Apis mellifera syriaca Venom: Evaluation of its anticoagulant effect, proteolytic activity, and cytotoxicity along with its two main compounds\u2014mel and PLA2\u2014ON hela cancer cells. Molecules  2022,27(5),1653","journal-title":"Molecules"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"69380","DOI":"10.1371\/journal.pone.0069380","volume":"8","author":"Shin J.M.","year":"2013","unstructured":"Shin J.M.; Jeong Y.J.; Cho H.J.; Melittin suppresses HIF-1\u03b1\/VEGF expression through inhibition of ERK and mTOR\/p70S6K pathway in human cervical carcinoma cells. PLoS One  2013,8(7),69380","journal-title":"PLoS One"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/ph17020195","volume":"17","author":"Qannita R.A.","year":"2024","unstructured":"Qannita R.A.; Alalami A.I.; Harb A.A.; Targeting hypoxia-inducible factor-1 (HIF-1) in cancer: Emerging therapeutic strategies and pathway regulation. Pharmaceuticals  2024,17(2),195","journal-title":"Pharmaceuticals"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.eururo.2015.08.037","volume":"69","author":"Dobruch J.","year":"2016","unstructured":"Dobruch J.; Daneshmand S.; Fisch M.; Gender and bladder cancer: A collaborative review of etiology, biology, and outcomes. Eur Urol  2016,69(2),300-310","journal-title":"Eur Urol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","volume":"9","author":"Dyrskj\u00f8t L.","year":"2023","unstructured":"Dyrskj\u00f8t L.; Hansel D.E.; Efstathiou J.A.; Bladder cancer. Nat Rev Dis Primers  2023,9(1),58","journal-title":"Nat Rev Dis Primers"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","volume":"33","author":"Powles T.","year":"2022","unstructured":"Powles T.; Bellmunt J.; Comperat E.; Bladder cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol  2022,33(3),244-58","journal-title":"Ann Oncol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"215615","DOI":"10.1016\/j.canlet.2022.215615","volume":"534","author":"Yan R.","year":"2022","unstructured":"Yan R.; Dai W.; Wu R.; Huang H.; Shu M.; Therapeutic targeting m6A-guided miR-146a-5p signaling contributes to the melittin-induced selective suppression of bladder cancer. Cancer Lett  2022,534,215615","journal-title":"Cancer Lett"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41422-018-0040-8","volume":"28","author":"Yang Y.","year":"2018","unstructured":"Yang Y.; Hsu P.J.; Chen Y.S.; Yang Y.G.; Dynamic transcriptomic m6A decoration: Writers, erasers, readers and functions in RNA metabolism. Cell Res  2018,28(6),616-24","journal-title":"Cell Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/jcmm.14775","volume":"24","author":"Yao J.","year":"2020","unstructured":"Yao J.; Zhang Z.; Li S.; Li B.; Wang X.H.; Melittin inhibits proliferation, migration and invasion of bladder cancer cells by regulating key genes based on bioinformatics and experimental assays. J Cell Mol Med  2020,24(1),655-70","journal-title":"J Cell Mol Med"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"10482","DOI":"10.1038\/s41598-024-61302-0","volume":"14","author":"Cheng G.","year":"2024","unstructured":"Cheng G.; Zhou Z.; Li S.; Predicting bladder cancer survival with high accuracy: Insights from MAPK pathway-related genes. Sci Rep  2024,14(1),10482","journal-title":"Sci Rep"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12964-024-01998-9","volume":"22","author":"Chen T.","year":"2024","unstructured":"Chen T.; Lin X.; Lu S.; Li B.; V-ATPase in cancer: Mechanistic insights and therapeutic potentials. Cell Commun Signal  2024,22(1),613","journal-title":"Cell Commun Signal"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/5038172","volume":"2018","author":"Jin Z.","year":"2018","unstructured":"Jin Z.; Yao J.; Xie N.; Melittin Constrains the Expression of Identified Key Genes Associated with Bladder Cancer. J Immunol Res  2018,2018,1-16","journal-title":"J Immunol Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1440-1681.2007.04725.x","volume":"34","author":"Faber E.S.L.","year":"2007","unstructured":"Faber E.S.L.; Sah P.; Functions of SK channels in central neurons. Clin Exp Pharmacol Physiol  2007,34(10),1077-83","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"115774","DOI":"10.1016\/j.bcp.2023.115774","volume":"216","author":"Dupuy M.","year":"2023","unstructured":"Dupuy M.; Gueguinou M.; Potier-Cartereau M.; SKCa- and Kv1-type potassium channels and cancer: Promising therapeutic targets? Biochem Pharmacol  2023,216,115774","journal-title":"Biochem Pharmacol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3390\/membranes13060583","volume":"13","author":"Vasileva V.Y.","year":"2023","unstructured":"Vasileva V.Y.; Khairullina Z.M.; Sudarikova A.V.; Chubinskiy-Nadezhdin V.I.; Role of calcium-activated potassium channels in proliferation, migration and invasion of human chronic myeloid leukemia K562 cells. Membranes  2023,13(6),583","journal-title":"Membranes"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/cancers15041027","volume":"15","author":"Varricchio A.","year":"2023","unstructured":"Varricchio A.; Khan S.; Price Z.K.; Davis R.A.; Ramesh S.A.; Yool A.J.; Pharmacological inhibition of membrane signaling mechanisms reduces the invasiveness of U87-MG and U251-MG glioblastoma cells in vitro. Cancers  2023,15(4),1027","journal-title":"Cancers"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/j.1476-5381.2010.01044.x","volume":"162","author":"Potier M.","year":"2011","unstructured":"Potier M.; Chantome A.; Joulin V.; The SK3\/K Ca 2.3 potassium channel is a new cellular target for edelfosine. Br J Pharmacol  2011,162(2),464-79","journal-title":"Br J Pharmacol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.jep.2009.12.007","volume":"127","author":"Cho H.J.","year":"2010","unstructured":"Cho H.J.; Jeong Y.J.; Park K.K.; Bee venom suppresses PMA-mediated MMP-9 gene activation via JNK\/p38 and NF-\u03baB-dependent mechanisms. J Ethnopharmacol  2010,127(3),662-8","journal-title":"J Ethnopharmacol"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10059-010-0028-9","volume":"29","author":"Park J.H.","year":"2010","unstructured":"Park J.H.; Jeong Y.J.; Park K.K.; Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Mol Cells  2010,29(2),209-16","journal-title":"Mol Cells"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/jcp.1041620202","volume":"162","author":"Woodfork K.A.","year":"1995","unstructured":"Woodfork K.A.; Wonderlin W.F.; Peterson V.A.; Strobl J.S.; Inhibition of ATP\u2010sensitive potassium channels causes reversible cell\u2010cycle arrest of human breast cancer cells in tissue culture. J Cell Physiol  1995,162(2),163-171","journal-title":"J Cell Physiol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.3390\/toxins7072422","volume":"7","author":"Li D.","year":"2015","unstructured":"Li D.; Lee Y.; Kim W.; Lee K.; Bae H.; Kim S.; Analgesic effects of bee venom derived phospholipase A2 in a mouse model of oxaliplatin-induced neuropathic pain. Toxins  2015,7(7),2422-34","journal-title":"Toxins"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40035-019-0167-7","volume":"8","author":"Ham H.J.","year":"2019","unstructured":"Ham H.J.; Han S.B.; Yun J.; Bee venom phospholipase A2 ameliorates amyloidogenesis and neuroinflammation through inhibition of signal transducer and activator of transcription-3 pathway in Tg2576 mice. Transl Neurodegener  2019,8(1),26","journal-title":"Transl Neurodegener"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.3390\/molecules26082264","volume":"26","author":"Yaacoub C.","year":"2021","unstructured":"Yaacoub C.; Rifi M.; El-Obeid D.; The cytotoxic effect of Apis mellifera venom with a synergistic potential of its two main components\u2014melittin and PLA2\u2014On colon cancer HCT116 cell lines. Molecules  2021,26(8),2264","journal-title":"Molecules"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"134160","DOI":"10.1016\/j.molstruc.2022.134160","volume":"1272","author":"Maani Z.","year":"2023","unstructured":"Maani Z.; Farajnia S.; Rahbarnia L.; Hosseingholi E.Z.; Khajehnasiri N.; Mansouri P.; Rational design of an anti-cancer peptide inhibiting CD147 \/ Cyp A interaction. J Mol Struct  2023,1272,134160","journal-title":"J Mol Struct"},{"key":"ref=82","first-page":"111","volume":"3","author":"Saeed W.S.E.","year":"2017","unstructured":"Saeed W.S.E.; Khalil E.A.G.; Toxic effects and safety of bee venom protein [Melittin] in mice: Search for natural vaccine adjuvants. J Nat Prod Resour  2017,3(1),111-4","journal-title":"J Nat Prod Resour"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40360-021-00503-z","volume":"22","author":"Askari P.","year":"2021","unstructured":"Askari P.; Namaei M.H.; Ghazvini K.; Hosseini M.; In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteria. BMC Pharmacol Toxicol  2021,22(1),42","journal-title":"BMC Pharmacol Toxicol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.toxicon.2015.12.005","volume":"110","author":"Gajski G.","year":"2016","unstructured":"Gajski G.; Domijan A.M.; \u017degura B.; Melittin induced cytogenetic damage, oxidative stress and changes in gene expression in human peripheral blood lymphocytes. Toxicon  2016,110,56-67","journal-title":"Toxicon"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1186\/s12951-023-02223-4","volume":"21","author":"Yu X.","year":"2023","unstructured":"Yu X.; Jia S.; Yu S.; Recent advances in melittin-based nanoparticles for antitumor treatment: From mechanisms to targeted delivery strategies. J Nanobiotechnology  2023,21(1),454","journal-title":"J Nanobiotechnology"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"065102","DOI":"10.1088\/1361-6528\/ab5084","volume":"31","author":"Qi J.","year":"2020","unstructured":"Qi J.; Chen Y.; Xue T.; Graphene oxide-based magnetic nanocomposites for the delivery of melittin to cervical cancer HeLa cells. Nanotechnology  2020,31(6),065102","journal-title":"Nanotechnology"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jconrel.2024.08.047","volume":"375","author":"Duan X.","year":"2024","unstructured":"Duan X.; Zou H.; Yang J.; Liu S.; Xu T.; Ding J.; Melittin-incorporated nanomedicines for enhanced cancer immunotherapy. J Control Release  2024,375,285-299","journal-title":"J Control Release"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"108344","DOI":"10.1016\/j.bioorg.2025.108344","volume":"159","author":"Liu Q.","year":"2025","unstructured":"Liu Q.; Jia S.X.; Chi Q.N.; Efficient synthesis, stability-guided optimization and anticancer evaluation of bee venom peptide Melittin. Bioorg Chem  2025,159,108344","journal-title":"Bioorg Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"867","DOI":"10.3390\/ijms25020867","volume":"25","author":"Huang S.","year":"2024","unstructured":"Huang S.; Su G.; Jiang S.; Chen L.; Huang J.; Yang F.; New N-terminal fatty-acid-modified melittin analogs with potent biological activity. Int J Mol Sci  2024,25(2),867","journal-title":"Int J Mol Sci"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"121706","DOI":"10.1016\/j.biomaterials.2022.121706","volume":"288","author":"Tang S.","year":"2022","unstructured":"Tang S.; Zhou L.; He H.; MnO2-melittin nanoparticles serve as an effective anti-tumor immunotherapy by enhancing systemic immune response. Biomaterials  2022,288,121706","journal-title":"Biomaterials"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"42533","DOI":"10.1021\/acsami.1c14285","volume":"13","author":"Jia F.","year":"2021","unstructured":"Jia F.; Chen P.; Wang D.; Bottlebrush polymer-conjugated melittin exhibits enhanced antitumor activity and better safety profile. ACS Appl Mater Interfaces  2021,13(36),42533-42542","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"103078","DOI":"10.1016\/j.jddst.2021.103078","volume":"68","author":"Qi J.","year":"2022","unstructured":"Qi J.; Liu Y.; Xu H.; Xue T.; Su Y.; Lin Z.; Anti-cancer effect of melittin-Au25(MHA)18 complexes on human cervical cancer HeLa cells. J Drug Deliv Sci Technol  2022,68,103078","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"105329","DOI":"10.1016\/j.bioorg.2021.105329","volume":"116","author":"Mansour G.H.","year":"2021","unstructured":"Mansour G.H.; El-Magd M.A.; Mahfouz D.H.; Bee venom and its active component Melittin synergistically potentiate the anticancer effect of Sorafenib against HepG2 cells. Bioorg Chem  2021,116,105329","journal-title":"Bioorg Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1038\/s41598-023-50729-6","volume":"14","author":"Khamis A.A.","year":"2024","unstructured":"Khamis A.A.; Ali E.M.M.; Salim E.I.; El-Moneim M.A.A.; Synergistic effects of bee venom, hesperidin, and piperine with tamoxifen on apoptotic and angiogenesis biomarker molecules against xerographic MCF-7 injected rats. Sci Rep  2024,14(1),1510","journal-title":"Sci Rep"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3892\/ol.2017.7366","volume":"15","author":"Wan L.","year":"2018","unstructured":"Wan L.; Zhang D.; Zhang J.; Ren L.; TT-1, an analog of melittin, triggers apoptosis in human thyroid cancer TT cells via regulating caspase, Bcl-2 and Bax. Oncol Lett  2018,15(1),1271-8","journal-title":"Oncol Lett"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/cbdd.12325","volume":"84","author":"Ma Q.","year":"2014","unstructured":"Ma Q.; Jiao W.; Lv Y.; Dong N.; Zhu X.; Shan A.; Structure-function relationship of Val\/Arg-rich peptides: Effects of net charge and pro on activity. Chem Biol Drug Des  2014,84(3),348-353","journal-title":"Chem Biol Drug Des"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"6901","DOI":"10.3892\/ol.2017.7018","volume":"14","author":"Xu T.","year":"2017","unstructured":"Xu T.; Cui T.; Peng L.; Kong S.; Zou J.; Tian X.; The anti-hepatocellular carcinoma activity of Mel-P15 is mediated by natural killer cells. Oncol Lett  2017,14(6),6901-6906","journal-title":"Oncol Lett"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00726-018-2596-5","volume":"50","author":"Akbari R.","year":"2018","unstructured":"Akbari R.; Hakemi Vala M.; Hashemi A.; Aghazadeh H.; Sabatier J.M.; Pooshang Bagheri K.; Action mechanism of melittin-derived antimicrobial peptides, MDP1 and MDP2, de novo designed against multidrug resistant bacteria. Amino Acids  2018,50(9),1231-43","journal-title":"Amino Acids"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00726-022-03180-2","volume":"54","author":"Akbari R.","year":"2022","unstructured":"Akbari R.; Hakemi Vala M.; Sabatier J.M.; Pooshang Bagheri K.; Fast killing kinetics, significant therapeutic index, and high stability of melittin-derived antimicrobial peptide. Amino Acids  2022,54(9),1275-85","journal-title":"Amino Acids"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/19768354.2022.2099971","volume":"26","author":"Jung H.","year":"2022","unstructured":"Jung H.; Kim Y.S.; Jung D.M.; Lee K.S.; Lee J.M.; Kim K.K.; Melittin-derived peptides exhibit variations in cytotoxicity and antioxidant, anti-inflammatory and allergenic activities. Anim Cells Syst  2022,26(4),158-165","journal-title":"Anim Cells Syst"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/B978-0-12-391860-4.00002-1","volume":"508","author":"Pan H.","year":"2012","unstructured":"Pan H.; Marsh J.N.; Christenson E.T.; Soman N.R.; Ivashyna O.; Lanza G.M.; Postformulation peptide drug loading of nanostructures. Methods Enzymol  2012,508,17-39","journal-title":"Methods Enzymol"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501424902260115203324","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/251339\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113894501424902260115203324","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:59:30Z","timestamp":1789703970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/251339\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113894501424902260115203324","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-08-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}